GGrantIndex
← Leaderboards

Marc A. Shuman

University Of California San Francisco

$13,809,068
Attributed
$13,809,068
Total exposure
6
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.9M · FY200513
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$16,840,121 · 7

By mechanism

P50$12,257,608 · 3
P01$3,241,598 · 2
T32$1,340,915 · 1
P30$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Neoplasm /Cancer Genetics

Research focus

Neoplasm /Cancer GeneticsAngiogenesisProstate NeoplasmsNeoplastic ProcessMetastasisNeoplastic GrowthGenetically Modified AnimalsHuman TissueLaboratory MouseProtease InhibitorBasic ScienceHematologyOncologyNuclear Magnetic Resonance SpectroscopyNeoplasm /Cancer ChemotherapyPlasminogen Activator InhibitorsPrognosisBreast NeoplasmsExtracellular MatrixModel Design /DevelopmentGene ExpressionPlasminMonoclonal AntibodyDisease /Disorder Model

Grant awards (29)

Basic Research in Hematology and Oncology$190,138
T32 · FY2013 · DK · contact PI
Basic Research in Hematology and Oncology$186,693
T32 · FY2012 · DK · contact PI
Basic Research in Hematology and Oncology$108,560
T32 · FY2011 · DK · contact PI
Basic Research in Hematology and Oncology$189,607
T32 · FY2010 · DK · contact PI
Basic Research in Hematology and Oncology$189,607
T32 · FY2009 · DK · contact PI
Basic Research in Hematology and Oncology$244,251
T32 · FY2008 · DK · contact PI
Basic Research in Hematology and Oncology$232,059
T32 · FY2007 · DK · contact PI
UCSF PROSTATE CANCER SPORE$1,878,533
P50 · FY2005 · CA
UCSF PROSTATE CANCER SPORE$60,000
P50 · FY2005 · CA
UCSF PROSTATE CANCER SPORE$2,265,599
P50 · FY2003 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$59,571
P01 · FY2003 · CA
UCSF PROSTATE CANCER SPORE$2,195,771
P50 · FY2002 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$347,904
P01 · FY2002 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2002 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2002 · CA
PROTEASES--TUMOR BIOLOGY$0
P01 · FY2002 · CA
UCSF PROSTATE CANCER SPORE$2,320,920
P50 · FY2001 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$1,328,283
P01 · FY2001 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2001 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2001 · CA
Genitourinary oncology program$0
P30 · FY2001 · CA
Genitourinary oncology program$0
P30 · FY2001 · CA
PROTEASES--TUMOR BIOLOGY$0
P01 · FY2001 · CA
UCSF PROSTATE CANCER SPORE$2,341,539
P50 · FY2000 · CA
PROTEASES IN CANCER--BIOLOGY AND DRUG DEVELOPMENT$1,295,295
P01 · FY2000 · CA
PROTEASES--TUMOR BIOLOGY$210,545
P01 · FY2000 · CA
THERAPEUTIC BLOCKADE OF THE UROKINASE RECEPTOR$206,819
P50 · FY2000 · CA
C-MPL LIGAND IN HEALTH AND DISEASE$161,151
P50 · FY2000 · HL
Genitourinary oncology program$0
P30 · FY2000 · CA